GDTC insider buying and SEC filings, explained
CytoMed Therapeutics Ltd · CIK 1873093
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$429K
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jul 14–20, 2026 | Purchase (code P) Amended filing | Chee Kong Choo (Director and 10% owner) bought 200,000 shares between Jul 14 and Jul 20 at $1.50 ($300K), reported as a purchase (code P). Holdings up 46% to 630,324 shares. Not marked as a 10b5-1 plan trade. This amends a filing from Jul 24. | SEC filing Filed Jul 24, 2026 |
| May 13, 2026 | Purchase (code P) | Chee Kong Choo (Director and 10% owner) bought 112,000 shares at $1.15 ($129K), reported as a purchase (code P). Holdings up 35% to 430,324 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 15, 2026 |
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow GDTC in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.